MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has received results from the first 10 patients who participated in the Phase 2 clinical trial undertaken by MMJ's wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Ltd.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that it has entered into an agreement to acquire a strategic stake in private, Canadian-based healthcare company Dosecann Inc., via the proposed placement of C$2.5 million in secured convertible debenture units.
Tianmei Beverage Group Corporation Limited (ASX:TB8) is pleased to announce that it has commissioned a specialist independent blockchain solution company to design and implementation a new blockchain system to synergise and integrate with the existing enterprise systems.
The world's largest monosodium glutamate and xanthan gum producer and a major supplier for a series of bio-fermentation products, Fufeng Group Limited (HKG:0546) and Evonik entered into a cooperation agreement for the production of ThreAMINO(R) (L-Threonine).
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that its partly-owned TSX-V listed subsidiary, Harvest One Cannabis Inc. (CVE:HVST), has released two announcements regarding its intentions to undertake a fully underwritten short form prospectus offer to raise up to $25,000,000 initially and then subsequently increased to $35,000,000 (excluding over-allotments) due to strong investor demand.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise that TSX-V listed Harvest One Cannabis Inc. (CVE:HVST), which is 59% owned by MMJ, has released an operational update in relation to its wholly-owned horticultural subsidiary United Greeneries Ltd.
MMJ PhytoTech Limited (ASX:MMJ) is pleased to advise shareholders that the Company welcomes the recent announcement (4 January 2018) made by Federal Government Health Minister Mr. Greg Hunt outlining the Government's plans to allow the export of medicinal cannabis products from Australia.
